Sara Humphreys

Enthusiast
DISC Type : i

Scientific Director, Pharmacokinetics and Drug Metabolism at Amgen

South San Francisco, California, United States

Overview

Sara Humphreys is a Scientific Director at Amgen, focusing on Pharmacokinetics and Drug Metabolism. A PhD graduate from Washington State University, she is a leader in translational ADME and PK/PD for emerging modalities like targeted protein degraders, ADCs, and oligonucleotides, supporting programs from discovery through Phase III.

Originally from a sheep farm in rural New Zealand, Sara was awarded a Fulbright Scholarship to pursue her PhD in the United States. She is a member of the American Society for Pharmacology and Experimental Therapeutics and has advocated for increased funding for biomedical research.

As a PhD candidate, she was selected as an ASPET Washington Fellow to engage with Congress on biomedical research funding.

Personality Overview

Consensus Focused

Amiable & Agreeable

Non-Confrontational

They prefer to build relationships rather than staying totally transactional.  They tend to be agreeable by nature, so take their promises with a pinch of salt.
 Unlike D or C types, they are convinced more by stories and testimonials.

Topics They Care About

Emerging Therapeutics
Leads teams at Amgen focused on ADME and PK/PD for targeted protein degraders, ADCs, and oligonucleotides, and has co-authored multiple related publications.
Drug Metabolism (PKDM)
Her core expertise and role at Amgen involves the characterization and translation of pharmacokinetic and drug metabolism data to support drug development.
Translational Science
Focuses on applying diverse data to address critical questions about IVIVC, PK/PD, and species translation for new drug modalities.

Media Appearances

Sara has no verified media appearances

Work History

3-2025
Scientific Director, Pharmacokinetics and Drug Metabolism at Amgen
4-2024 - 3-2025
Scientific Associate Director at Amgen
9-2021 - 4-2024
Principal Scientist at Amgen
5-2016 - 3-2017
Postdoctoral Researcher with Jeff Jones at Washington State University
1-2016 - 1-2017
ASPET Washington Fellow at American Society of Pharmacology and Experimental Therapeutics

Education

2010 - 2016
PhD from Washington State University
2009 - 2010
PGDipSci (Distinction) from University of Auckland

More Information

Social Presence :

Prographics :

Exp : 9 Location : South San Francisco, California, United States Job Level : Mid-senior Designation : Scientific Director, Pharmacokinetics and Drug Metabolism at Amgen
URL has been copied!

Insights For Selling To Sara

During A Call Or A Meeting

DO's

  • Ask them how their day is going or exchange some other pleasantries
  • Speak from experience about success that the product has seen with other customers
  • Give them the opportunity to lead the conversation where possible

DONT's

  • Don’t be excessively objective, be like a storyteller with them
  • Don’t push them for a direct ‘no’, take lack of ‘yes’ as ‘no’ after some time
  • Avoid overloading them with too much information

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Sara is

  • Relationship and rapport are valuable for them, but so is proven product value.
  • Will you ever get a clear answer from Sara

  • They are unlikely to say no directly.

Insights For Deal Planning

    How fast (or slow) will Sara move?

  • They are not very fast decision makers, even while they continue to stay engaged.
  • Can Sara take some risk or not?

  • They can take some low-probability risks if needed.

You And Sara

Personality Compatibility


Other Amgen Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.